Literature DB >> 28703626

Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors.

Stephen T Vernon1,2, Sean Coffey1,3, Ravinay Bhindi1,2, Soon Yeng Soo Hoo1, Gregory I Nelson1, Michael R Ward1, Peter S Hansen1, Kaleab N Asrress1,2, Clara K Chow2,4,5, David S Celermajer2,6, John F O'Sullivan2,7, Gemma A Figtree1,2.   

Abstract

Aims Identification and management of the Standard Modifiable Cardiovascular Risk Factors (SMuRFs; hypercholesterolaemia, hypertension, diabetes and smoking) has substantially improved cardiovascular disease outcomes. However, cardiovascular disease remains the leading cause of death worldwide. Suspecting an evolving pattern of risk factor profiles in the ST elevation myocardial infarction (STEMI) population with the improvements in primary care, we hypothesized that the proportion of 'SMuRFless' STEMI patients may have increased. Methods/results We performed a single centre retrospective study of consecutive STEMI patients presenting from January 2006 to December 2014. Over the study period 132/695 (25%) STEMI patients had 0 SMuRFs, a proportion that did not significantly change with age, gender or family history. The proportion of STEMI patients who were SMuRFless in 2006 was 11%, which increased to 27% by 2014 (odds ratio 1.12 per year, 95% confidence interval: 1.04-1.22). The proportion of patients with hypercholesterolaemia decreased (odds ratio 0.92, 95% confidence interval 0.86-0.98), as did the proportion of current smokers (odds ratio 0.93, 95% confidence interval 0.86-0.99), with no significant change in the proportion of patients with diabetes and hypertension. SMuRF status was not associated with extent of coronary disease; in-hospital outcomes, or discharge prescribing patterns. Conclusion The proportion of STEMI patients with STEMI poorly explained by SMuRFs is high, and is significantly increasing. This highlights the need for bold approaches to discover new mechanisms and markers for early identification of these patients, as well as to understand the outcomes and develop new targeted therapies.

Entities:  

Keywords:  Myocardial infarction; atherosclerosis; coronary artery disease; risk factors

Mesh:

Year:  2017        PMID: 28703626     DOI: 10.1177/2047487317720287

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  21 in total

1.  Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry.

Authors:  Sidong Li; Xiaojin Gao; Jingang Yang; Haiyan Xu; Yang Wang; Yanyan Zhao; Lu Yin; Chao Wu; Yi Wang; Yang Zheng; Bao Li; Xuan Zhang; Yunqing Ye; Rui Fu; Qiuting Dong; Hui Sun; Xinxin Yan; Yuan Wu; Jun Zhang; Chen Jin; Wei Li; Yuejin Yang
Journal:  BMC Med       Date:  2022-07-06       Impact factor: 11.150

Review 2.  Mental Stress and Cardiovascular Health-Part I.

Authors:  Federico Vancheri; Giovanni Longo; Edoardo Vancheri; Michael Y Henein
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

3.  Metabolic Signatures in Coronary Artery Disease: Results from the BioHEART-CT Study.

Authors:  Stephen T Vernon; Owen Tang; Taiyun Kim; Adam S Chan; Katharine A Kott; John Park; Thomas Hansen; Yen C Koay; Stuart M Grieve; John F O'Sullivan; Jean Y Yang; Gemma A Figtree
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

4.  Comparison of Mortality Outcomes in Acute Myocardial Infarction Patients With or Without Standard Modifiable Cardiovascular Risk Factors.

Authors:  Ching-Hui Sia; Junsuk Ko; Huili Zheng; Andrew Fu-Wah Ho; David Foo; Ling-Li Foo; Patrick Zhan-Yun Lim; Boon Wah Liew; Ping Chai; Tiong-Cheng Yeo; James W L Yip; Terrance Chua; Mark Yan-Yee Chan; Jack Wei Chieh Tan; Gemma Figtree; Heerajnarain Bulluck; Derek J Hausenloy
Journal:  Front Cardiovasc Med       Date:  2022-04-14

5.  Correlation of Triiodothyronine Level with In-Hospital Cardiac Function and Long-Term Prognosis in Patients with Acute Myocardial Infarction.

Authors:  Jianqing She; Jiahao Feng; Yangyang Deng; Lizhe Sun; Yue Wu; Manyun Guo; Xiao Liang; Jingjin Li; Yulong Xia; Zuyi Yuan
Journal:  Dis Markers       Date:  2018-12-02       Impact factor: 3.434

6.  Carotid artery intima-media thickness, distensibility and elasticity: population epidemiology and concordance in Australian children aged 11-12 years old and their parents.

Authors:  Richard S Liu; Sophie Dunn; Anneke C Grobler; Katherine Lange; Denise Becker; Greta Goldsmith; John B Carlin; Markus Juonala; Melissa Wake; David P Burgner
Journal:  BMJ Open       Date:  2019-07-04       Impact factor: 2.692

7.  Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study.

Authors:  Katharine A Kott; Stephen T Vernon; Thomas Hansen; Christine Yu; Kristen J Bubb; Sean Coffey; David Sullivan; Jean Yang; John O'Sullivan; Clara Chow; Sanjay Patel; James Chong; David S Celermajer; Leonard Kritharides; Stuart M Grieve; Gemma A Figtree
Journal:  BMJ Open       Date:  2019-09-18       Impact factor: 2.692

8.  A Cross-Cohort Study Examining the Associations of Metabolomic Profile and Subclinical Atherosclerosis in Children and Their Parents: The Child Health CheckPoint Study and Avon Longitudinal Study of Parents and Children.

Authors:  Markus Juonala; Susan Ellul; Debbie A Lawlor; Diana L Santos Ferreira; John B Carlin; Michael Cheung; Terence Dwyer; Melissa Wake; Richard Saffery; David P Burgner
Journal:  J Am Heart Assoc       Date:  2019-07-09       Impact factor: 5.501

9.  ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?

Authors:  Stephen T Vernon; Sean Coffey; Mario D'Souza; Clara K Chow; Jens Kilian; Karice Hyun; James A Shaw; Mark Adams; Philip Roberts-Thomson; David Brieger; Gemma A Figtree
Journal:  J Am Heart Assoc       Date:  2019-11-01       Impact factor: 5.501

10.  Progression of coronary atherosclerosis in patients without standard modifiable risk factors.

Authors:  Jawad Mazhar; Gemma Figtree; Stephen T Vernon; Keyvan Karimi Galougahi; Julie Carlo; Steven E Nissen; Stephen J Nicholls
Journal:  Am J Prev Cardiol       Date:  2020-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.